FI81350C - Analogfoerfarande foer framstaellning av nya, farmakologiskt aktiva 6-substituerade s-triatsolo/3,4-a/ ftalazinderivat. - Google Patents

Analogfoerfarande foer framstaellning av nya, farmakologiskt aktiva 6-substituerade s-triatsolo/3,4-a/ ftalazinderivat. Download PDF

Info

Publication number
FI81350C
FI81350C FI830100A FI830100A FI81350C FI 81350 C FI81350 C FI 81350C FI 830100 A FI830100 A FI 830100A FI 830100 A FI830100 A FI 830100A FI 81350 C FI81350 C FI 81350C
Authority
FI
Finland
Prior art keywords
formula
group
triazolo
phthalazine
phenyl
Prior art date
Application number
FI830100A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI830100L (fi
FI81350B (fi
FI830100A0 (fi
Inventor
Giorgio Tarzia
Emilio Occelli
Domenico Barone
Adele Giunta
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of FI830100A0 publication Critical patent/FI830100A0/fi
Publication of FI830100L publication Critical patent/FI830100L/fi
Publication of FI81350B publication Critical patent/FI81350B/fi
Application granted granted Critical
Publication of FI81350C publication Critical patent/FI81350C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • C07D237/34Phthalazines with nitrogen atoms directly attached to carbon atoms of the nitrogen-containing ring, e.g. hydrazine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
FI830100A 1982-01-18 1983-01-12 Analogfoerfarande foer framstaellning av nya, farmakologiskt aktiva 6-substituerade s-triatsolo/3,4-a/ ftalazinderivat. FI81350C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8201273 1982-01-18
GB8201273 1982-01-18

Publications (4)

Publication Number Publication Date
FI830100A0 FI830100A0 (fi) 1983-01-12
FI830100L FI830100L (fi) 1983-07-19
FI81350B FI81350B (fi) 1990-06-29
FI81350C true FI81350C (fi) 1990-10-10

Family

ID=10527683

Family Applications (1)

Application Number Title Priority Date Filing Date
FI830100A FI81350C (fi) 1982-01-18 1983-01-12 Analogfoerfarande foer framstaellning av nya, farmakologiskt aktiva 6-substituerade s-triatsolo/3,4-a/ ftalazinderivat.

Country Status (20)

Country Link
US (1) US4788186A (instruction)
EP (1) EP0085840B1 (instruction)
JP (1) JPS58124786A (instruction)
KR (1) KR890000184B1 (instruction)
AT (1) ATE22562T1 (instruction)
AU (1) AU564026B2 (instruction)
CA (1) CA1214168A (instruction)
DE (1) DE3366494D1 (instruction)
DK (1) DK163145C (instruction)
ES (1) ES8601995A1 (instruction)
FI (1) FI81350C (instruction)
GR (1) GR78442B (instruction)
HU (1) HU193033B (instruction)
IE (1) IE55032B1 (instruction)
IL (1) IL67697A (instruction)
NO (1) NO161674C (instruction)
NZ (1) NZ203021A (instruction)
PH (1) PH21834A (instruction)
PT (1) PT76107A (instruction)
ZA (1) ZA83224B (instruction)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1194310B (it) * 1983-07-12 1988-09-14 Lepetit Spa Derivati triazolo (3,4-a) ftalazinici 3,6-disostituiti
ATE236904T1 (de) * 1996-07-25 2003-04-15 Merck Sharp & Dohme Substituierte triazolo-pyridazin-derivate als liganden von gaba-rezeptoren
US6465462B1 (en) 1996-07-25 2002-10-15 Merck Sharp & Dohme Ltd. Substituted triazolo pyridazine derivatives as inverse agonists of the GABAAα5 receptor subtype
WO1998050385A1 (en) * 1997-05-08 1998-11-12 Merck Sharp & Dohme Limited SUBSTITUTED 1,2,4-TRIAZOLO[3,4-a]PHTHALAZINE DERIVATIVES AS GABA ALPHA 5 LIGANDS
GB9715977D0 (en) 1997-07-29 1997-10-01 Merck Sharp & Dohme Therapeutic agents
ES2137113B1 (es) * 1997-07-29 2000-09-16 Almirall Prodesfarma Sa Nuevos derivados de triazolo-piridazinas heterociclicos.
GB9723999D0 (en) 1997-11-13 1998-01-14 Merck Sharp & Dohme Therapeutic use
GB9726699D0 (en) * 1997-12-18 1998-02-18 Merck Sharp & Dohme Therapeutic use
GB9726701D0 (en) * 1997-12-18 1998-02-18 Merck Sharp & Dohme Therapeutic use
AU1041599A (en) * 1997-11-13 1999-06-07 Jose Luis Castro Pineiro Therapeutic uses of triazolo-pyridazine derivatives
GB9726702D0 (en) * 1997-12-18 1998-02-18 Merck Sharp & Dohme Therapeutic use
US6110915A (en) * 1997-12-18 2000-08-29 Merck & Co., Inc. Antiemetic use of triazolo-pyridazine derivatives
JP2002509150A (ja) * 1998-01-14 2002-03-26 メルク シャープ エンド ドーム リミテッド Gaba受容体のリガンドとしてのトリアゾロピリダジン誘導体
GB9801202D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801208D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801234D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
MXPA00007135A (es) 1998-01-21 2002-11-07 Merck Sharp & Dohme Derivados de triazolo-piridazina como ligandos para receptores gaba.
GB9801210D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801397D0 (en) 1998-01-22 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801538D0 (en) 1998-01-23 1998-03-25 Merck Sharp & Dohme Pharmaceutical product
US6448249B1 (en) 1998-02-25 2002-09-10 Merck Sharp & Dohme Ltd. Substituted 1,2,4-triazolo[3,4-A]phthalazine derivatives as GABAα5 ligands
PL341975A1 (en) * 1998-02-25 2001-05-07 Merck Sharp & Dohme Substituted 1,2,4-triazole[3,4-a]phtalazine
GB9824897D0 (en) 1998-11-12 1999-01-06 Merck Sharp & Dohme Therapeutic compounds
JP2002529468A (ja) 1998-11-12 2002-09-10 メルク エンド カムパニー インコーポレーテッド GABA−Aα−5逆活性薬の治療性多形およびそのパモエート組成物
GB9929569D0 (en) * 1999-12-14 2000-02-09 Merck Sharp & Dohme Therapeutic agents
GB0028583D0 (en) 2000-11-23 2001-01-10 Merck Sharp & Dohme Therapeutic compounds
WO2002083140A1 (en) * 2001-04-10 2002-10-24 Merck & Co., Inc. Inhibitors of akt activity
EP1379250A2 (en) * 2001-04-10 2004-01-14 Merck & Co., Inc. A method of treating cancer
AU2003226301A1 (en) * 2002-04-08 2003-10-20 Merck And Co., Inc. Method of treating cancer
US20050054647A1 (en) * 2002-12-27 2005-03-10 Detlev Schuppan New pharmaceutical combination
KR101368093B1 (ko) * 2004-09-02 2014-03-14 다케다 게엠베하 트리아졸로프탈라진
AU2006204454B2 (en) 2005-01-05 2011-11-10 Takeda Gmbh Triazolophthalazines as PDE2-inhibitors
ES2397082T3 (es) 2005-01-05 2013-03-04 Nycomed Gmbh Triazoloftalazinas como inhibidores de PDE2
PH12012501361A1 (en) 2009-12-31 2012-10-22 Centro Nac De Investigaciones Oncologicas Cnio Tricyclic compounds for use as kinase inhibitors
CN103694244B (zh) * 2014-01-09 2016-03-30 郑州大学 3,6位取代-1,2,4-三氮唑并[3,4-a]酞嗪类化合物及其制备和用途
CN104016986B (zh) * 2014-03-13 2016-02-03 郑州大学 3-取代-6-(1-取代哌嗪基)-1,2,4-三氮唑并[3,4-a]酞嗪类化合物、其制备方法和用途
EP4279074A1 (en) * 2022-05-19 2023-11-22 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin Azolo compounds for treatment of fibrotic diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB629177A (en) * 1945-12-21 1949-09-14 Ciba Ltd Manufacture of new hydrazine compounds and derivatives thereof
US2484029A (en) * 1945-12-21 1949-10-11 Ciba Pharm Prod Inc Hydrazine derivatives of pyridazine compounds
JPS5132598A (en) * 1974-09-13 1976-03-19 Eisai Co Ltd Toriazoro * 3 44 ee * futarajinjudotai no goseiho
JPS603080B2 (ja) * 1976-08-10 1985-01-25 三菱化学株式会社 S―トリアゾロ〔3,4 ―α〕〔5,6,7,8〕テトラヒドロ フタラジン類
GR70309B (instruction) * 1979-10-29 1982-09-08 Dow Chemical Co

Also Published As

Publication number Publication date
NO830110L (no) 1983-07-19
FI830100L (fi) 1983-07-19
ATE22562T1 (de) 1986-10-15
PH21834A (en) 1988-03-17
AU564026B2 (en) 1987-07-30
JPS58124786A (ja) 1983-07-25
US4788186A (en) 1988-11-29
KR890000184B1 (ko) 1989-03-09
CA1214168A (en) 1986-11-18
GR78442B (instruction) 1984-09-27
JPH048428B2 (instruction) 1992-02-17
IE830082L (en) 1983-07-18
FI81350B (fi) 1990-06-29
DE3366494D1 (de) 1986-11-06
PT76107A (en) 1983-02-01
ES531458A0 (es) 1985-11-01
EP0085840B1 (en) 1986-10-01
NO161674B (no) 1989-06-05
IL67697A (en) 1990-02-09
IL67697A0 (en) 1983-05-15
DK163145C (da) 1992-06-22
EP0085840A1 (en) 1983-08-17
DK17983A (da) 1983-07-19
IE55032B1 (en) 1990-05-09
ES8601995A1 (es) 1985-11-01
AU1055083A (en) 1983-07-28
ZA83224B (en) 1983-10-26
NO161674C (no) 1989-09-13
NZ203021A (en) 1986-05-09
KR840003254A (ko) 1984-08-20
FI830100A0 (fi) 1983-01-12
HU193033B (en) 1987-08-28
DK163145B (da) 1992-01-27
DK17983D0 (da) 1983-01-18

Similar Documents

Publication Publication Date Title
FI81350C (fi) Analogfoerfarande foer framstaellning av nya, farmakologiskt aktiva 6-substituerade s-triatsolo/3,4-a/ ftalazinderivat.
CN105209463B (zh) 2‑氨基吡啶并[4,3‑d]嘧啶‑5‑酮衍生物及其作为Wee‑1抑制剂的用途
EP0134946B1 (en) 3,6-Disubstituted-triazolo[3,4-a]phthalazine derivatives
US20060189631A1 (en) Substituted imidazopyrimidines for the prevention and treatment of cancer
CN110603256B (zh) 可用作wee-1激酶抑制剂的嘧啶并嘧啶酮
WO2018113584A1 (zh) Fgfr4抑制剂、其制备方法与药学上的应用
CA2706018A1 (en) 1, 5-dihydro-pyrazolo [3,4-d]pyrimidin-4-one derivatives and their use as pde9a modulators for the treatment of cns disorders
WO2016022460A1 (en) Potent dual brd4-kinase inhibitors as cancer therapeutics
CN113912648A (zh) 一种二氨基嘧啶化合物及包含该化合物的组合物
TWI472530B (zh) 蛋白質激酶抑制劑
CN102459193B (zh) 抗癌化合物和含有该化合物的药物组合物
JP2011530574A (ja) 2−アルキル−6−シクロアミノ−3−(ピリジン−4−イル)イミダゾ[1,2−ib]ピリダジン誘導体、この調製およびこの治療応用
Okuda et al. Polycyclic N‐Heterocyclic Compounds. Part 86: Synthesis and Evaluation of Antiplatelet Aggregation Activity of 2, 4‐Disubstituted 9‐Chloro‐5, 6‐dihydropyrimido [5, 4‐d] benzazepine and Related Compounds
HUP0002650A2 (hu) 4-Oxo-3,5-dihidro-4H-piridazino[4,5-b]-indol-1-acetamid-származékok, eljárás a vegyületek előállítására és a vegyületeket tartalmazó gyógyszerkészítmények
EP3397640B1 (en) Xanthine derivative inhibitors of bet proteins
CA2483496A1 (en) Inhibitors of checkpoint kinases (wee1 and chk1)
WO1997023456A1 (en) Indoloquinone derivatives as bioreductive agents
Cecchetti et al. Quinolinecarboxylic acids. 3. Synthesis and antibacterial evaluation of 2-substituted 7-oxo-2, 3-dihydro-7H-pyrido [1, 2, 3-de][1, 4] benzothiazine-6-carboxylic acids related to rufloxacin
Birch et al. Syntheses of flosequinan: a novel 4-quinolone shown to be useful in congestive heart failure
EP1150983A1 (en) Triazolo-pyridazine derivatives as ligands for gaba receptors
Barlin et al. Imidazo [1, 2-b] Pyridazines. XVI. Synthesis and Central Nervous System Activities of Some 6-(Chloro, Alkylthio, Phenylthio, Benzylthio or Pyridinylmethylthio)-3-(unsubstituted, benzamidomethyl or methoxy)-2-(styryl or benzoyl) imidazo [1, 2-b] pyridazines
Rosen et al. Discovery of potent cholecystokinin-2 receptor antagonists: Elucidation of key pharmacophore elements by X-ray crystallographic and NMR conformational analysis
Pozharskii et al. Proton sponges condensed with pyridazine and pyrrole nuclei
Uff et al. Studies concerning pyrrolo [2, 1‐a] phthalazines and related compounds
Skrzypek et al. Synthesis of 3-Alkanesulfonyl-4 (1H)-quinolinones from 3-Alkanesulfonyl-4-alkylsulfanylquinolines

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: GRUPPO LEPETIT S.P.A.